1. Home
  2. ELDN vs BRCC Comparison

ELDN vs BRCC Comparison

Compare ELDN & BRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • BRCC
  • Stock Information
  • Founded
  • ELDN 2004
  • BRCC 2014
  • Country
  • ELDN United States
  • BRCC United States
  • Employees
  • ELDN N/A
  • BRCC N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • BRCC Beverages (Production/Distribution)
  • Sector
  • ELDN Health Care
  • BRCC Consumer Staples
  • Exchange
  • ELDN Nasdaq
  • BRCC Nasdaq
  • Market Cap
  • ELDN 178.4M
  • BRCC 202.4M
  • IPO Year
  • ELDN N/A
  • BRCC N/A
  • Fundamental
  • Price
  • ELDN $2.68
  • BRCC $1.34
  • Analyst Decision
  • ELDN Strong Buy
  • BRCC Strong Buy
  • Analyst Count
  • ELDN 2
  • BRCC 4
  • Target Price
  • ELDN $12.50
  • BRCC $3.13
  • AVG Volume (30 Days)
  • ELDN 609.3K
  • BRCC 842.0K
  • Earning Date
  • ELDN 08-18-2025
  • BRCC 08-06-2025
  • Dividend Yield
  • ELDN N/A
  • BRCC N/A
  • EPS Growth
  • ELDN N/A
  • BRCC N/A
  • EPS
  • ELDN N/A
  • BRCC N/A
  • Revenue
  • ELDN N/A
  • BRCC $383,072,000.00
  • Revenue This Year
  • ELDN N/A
  • BRCC $6.16
  • Revenue Next Year
  • ELDN N/A
  • BRCC $11.09
  • P/E Ratio
  • ELDN N/A
  • BRCC N/A
  • Revenue Growth
  • ELDN N/A
  • BRCC N/A
  • 52 Week Low
  • ELDN $2.30
  • BRCC $1.19
  • 52 Week High
  • ELDN $5.54
  • BRCC $6.30
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 38.39
  • BRCC 32.19
  • Support Level
  • ELDN $2.60
  • BRCC $1.29
  • Resistance Level
  • ELDN $2.91
  • BRCC $1.42
  • Average True Range (ATR)
  • ELDN 0.17
  • BRCC 0.09
  • MACD
  • ELDN -0.02
  • BRCC -0.02
  • Stochastic Oscillator
  • ELDN 16.98
  • BRCC 21.93

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. it is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

Share on Social Networks: